LA
BSX icon

Latitude Advisors’s Boston Scientific BSX Stock Holding History

Latitude Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,722
Closed -$243K – 332
2021
Q4 		$243K Hold
5,722
– – 0.07% 254
2021
Q3 		$248K Buy
+5,722
New +$253K 0.08% 241

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Latitude Advisors's BSX Position: Q1 2022 in Review

Latitude Advisors sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 5,722 shares — an estimated $243K sold.

Latitude Advisors first reported a position in BSX in Q3 2021 and held it in 2 quarters. The position peaked at $248K in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Latitude Advisors reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Latitude Advisors sold 5,722 Boston Scientific shares in Q1 2022, an estimated $243K.
  • Latitude Advisors first reported a position in Boston Scientific in Q3 2021 and held it in 2 quarters.
  • Latitude Advisors's Boston Scientific position peaked at $248K in Q3 2021.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Latitude Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.